Acquisition will enable Agilent to provide a single informatics
solution across laboratory and operational domains
SANTA CLARA, Calif.--(BUSINESS WIRE)--May 2, 2018--
Agilent Technologies, Inc. (NYSE: A) today announced that it has entered
into a definitive agreement to acquire privately-held Genohm, a
developer of highly differentiated, on-premise and cloud-based software
solutions for laboratory management.
Genohm’s main laboratory software automation suite, SLIMS, is a digital
platform that provides laboratories with a rapidly deployable and
seamless laboratory information management system (LIMS) and electronic
lab notebook (ELN) environment that is used in biobanks, research labs
and next gen sequencing facilities. The platform tracks data and
samples, tests and users, results and workflows, from the original
material shipment to the result from lab instruments and in-silico
analysis pipelines. Genohm also has an application marketplace with
preconfigured workflows to enable rapid system implementation across a
broad range of industries and scientific workflows.
Customers are looking to generate better answers, and this requires
integrated informatics solutions. This acquisition enhances Agilent’s
current software portfolio, adding LIMS and workflow management, while
expanding ELN capability. This combination will allow Agilent to bring
greater context to analytical data, enabling scientists to generate
results more efficiently.
“We were impressed with the team and the technology,” said John Sadler,
Vice President and General Manager of Agilent’s Software and Informatics
Division. “The modern architecture of SLIMS is perfectly aligned with
the values of Agilent’s OpenLab products. By integrating this technology
with our broad and diverse instrument portfolio, we are in a unique
position to support and enhance the operations of modern
laboratories—truly helping our customers to do more with their data.”
“Genohm has an excellent footprint in the genomics space,” said Kamni
Vijay, Ph.D., Vice President and General Manager of Agilent’s Genomics
Division. “This acquisition supports our strategy to offer complete
next-generation sequencing workflows and improve the laboratory
management of our genomic customers.”
“We are very excited to join the Agilent team and believe that together
we can accelerate development of the digital lab to help our customers
advance science and discovery while ensuring compliance and
traceability,” said Frederik Decouttere, founder and CEO of Genohm. “Our
laboratory management platform is highly configurable, easily deployable
and leverageable across many different workflows, which makes our
technology a perfect fit for Agilent.”
Headquartered in Lausanne, Switzerland, Genohm has 40 employees.
The transaction is subject to closing conditions. Financial terms of the
deal are not being disclosed.
About Genohm
Genohm, originally founded in Ghent (Belgium) in 2002 as a small
two-person bio-informatics shop, re-established itself in 2011 as an
EPFL Start-Up at the Innovation Park in Lausanne (Switzerland), focusing
on guaranteeing compliance, traceability and big lab data management in
highly complex and continuously evolving lab environments. With the
successful launch of its main laboratory software automation suite,
SLIMS, Genohm officially entered the lab informatics market, proudly
serving a rapidly growing set of customers in widely varying research
and clinical environments throughout Europe, the Middle East, Asia
Pacific and the US. Today, Genohm has offices in Lausanne, Ghent, and
Durham NC and counts a workforce of 40+ highly trained software and life
sciences engineers. Information about Genohm is available at www.genohm.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences,
diagnostics, and applied chemical markets. With more than 50 years of
insight and innovation, Agilent instruments, software, services,
solutions, and people provide trusted answers to its customers' most
challenging questions. The company generated revenues of $4.47 billion
in fiscal 2017 and employs 14,200 people worldwide. Information about
Agilent is available at www.agilent.com.
Forward-Looking Statements
This news release contains forward-looking statements as defined in the
Securities Exchange Act of 1934 and is subject to the safe harbors
created therein. The forward-looking statements contained herein
include, but are not limited to, information regarding Agilent’s future
revenue, earnings and profitability; planned new products; market
trends; the future demand for the company’s products and services;
customer expectations; and revenue and non-GAAP earnings guidance for
the second quarter and full fiscal year 2018. These forward-looking
statements involve risks and uncertainties that could cause Agilent’s
results to differ materially from management’s current expectations.
Such risks and uncertainties include, but are not limited to, unforeseen
changes in the strength of our customers’ businesses; unforeseen changes
in the demand for current and new products, technologies, and services;
unforeseen changes in the currency markets; customer purchasing
decisions and timing, and the risk that we are not able to realize the
savings expected from integration and restructuring activities. In
addition, other risks that Agilent faces in running its operations
include the ability to execute successfully through business cycles; the
ability to meet and achieve the benefits of its cost-reduction goals and
otherwise successfully adapt its cost structures to continuing changes
in business conditions; ongoing competitive, pricing and gross-margin
pressures; the risk that our cost-cutting initiatives will impair our
ability to develop products and remain competitive and to operate
effectively; the impact of geopolitical uncertainties and global
economic conditions on our operations, our markets and our ability to
conduct business; the ability to improve asset performance to adapt to
changes in demand; the ability of our supply chain to adapt to changes
in demand; the ability to successfully introduce new products at the
right time, price and mix; the ability of Agilent to successfully
integrate recent acquisitions; the ability of Agilent to successfully
comply with certain complex regulations; and other risks detailed in
Agilent’s filings with the Securities and Exchange Commission, including
our quarterly report on Form 10-Q for the first quarter ended January
31, 2018. Forward-looking statements are based on the beliefs and
assumptions of Agilent’s management and on currently available
information. Agilent undertakes no responsibility to publicly update or
revise any forward-looking statement.
NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available on the Agilent news site at www.agilent.com/go/news.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180502006440/en/
Source: Agilent Technologies, Inc.
Agilent Technologies:
EDITORIAL CONTACTS:
Victoria
Wadsworth-Hansen (Business), +1 408-553-2005
+ 45 29336980
victoria.wadsworth-hansen@agilent.com
or
Stefanie
Notaney (Enterprise), +1 408-345-8955
stefanie.notaney@agilent.com
or
INVESTOR
CONTACT:
Alicia Rodriguez, +1 408-345-8948
alicia_rodriguez@agilent.com